1053 related items for PubMed ID: 8952741
1. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
[Abstract] [Full Text] [Related]
2. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
Maison-Blanche P, Brembilla-Perrot B, Fauchier JP, Babuty D, Garnier LF, Rouesnel P, Breuillac JC, Funck F, Scheck F, Peraudeau P, Medvedowsky JL.
Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
[Abstract] [Full Text] [Related]
3. [A randomized double-blind trial comparing cibenzoline and disopyramide in the prevention of recurrences of atrial tachyarrhythmia].
Piot O, Flammang D, Dambrine P, Cheikel J, Jouannon C, Graux P, Baudouy Y, Bine-Scheck F, Leenhardt A.
Arch Mal Coeur Vaiss; 1998 Dec; 91(12):1481-6. PubMed ID: 9891831
[Abstract] [Full Text] [Related]
4. [Long-term prevention of the recurrence of auricular fibrillation using cibenzoline. Multicenter study apropos of 89 case reports].
Frances Y, Luccioni R, Delaage M, Donnarel G, Medvedowsky JL, Quiret JC.
Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():99-103. PubMed ID: 3938266
[Abstract] [Full Text] [Related]
5. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].
Babuty D, Cosnay P, Rouesnel P, Bine-Scheck F, Arnaud R, Fauchier JP.
Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):225-34. PubMed ID: 1642441
[Abstract] [Full Text] [Related]
6. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
[Abstract] [Full Text] [Related]
7. [Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study].
Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
G Ital Cardiol; 1996 Apr 01; 26(4):379-90. PubMed ID: 8707022
[Abstract] [Full Text] [Related]
8. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC, Guo JH, Fang Q, Zheng YA, Sun YM, Zhu WQ, Wan Z, Guo JX, Ge JB, Han SM.
Zhonghua Yi Xue Za Zhi; 2005 Mar 30; 85(12):798-801. PubMed ID: 15949393
[Abstract] [Full Text] [Related]
9. [Study of the efficacy and tolerability of oral administration of cibenzoline in the prevention of recurrence of symptomatic atrial fibrillation].
Medvedowsky JL, Bine-Scheck F, Dambrine P, Domerego JJ, Garnier LF, Labaki F, Piechaczyk P, Rouesnel P, Schenowitz A.
Ann Cardiol Angeiol (Paris); 1994 Feb 30; 43(2):89-96. PubMed ID: 8172484
[Abstract] [Full Text] [Related]
10. [The efficacy of propafenone in preventing recurrent auricular fibrillation and flutter].
López Gil M, Karoni AW, Reinoso MA, Márquez L, García-Cosío F.
Rev Esp Cardiol; 1991 Feb 30; 44(7):435-40. PubMed ID: 1759024
[Abstract] [Full Text] [Related]
11. Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial.
Madonia S, De Simone M, Brai G, Gozzo D, Gristina A, Luciano L, Maisano S, Migliore G, Mineo R, Muzzo MP, Nicchi F, Randazzo A, Raspanti G, Rotolo G, Russo A, Sagona F, Schirosa M, Spinello M, Stancampiano R, Geraci E.
Ital Heart J; 2000 Jul 30; 1(7):475-9. PubMed ID: 10933330
[Abstract] [Full Text] [Related]
12. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
[Abstract] [Full Text] [Related]
13. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
Roy D, Talajic M, Dorian P, Connolly S, Eisenberg MJ, Green M, Kus T, Lambert J, Dubuc M, Gagné P, Nattel S, Thibault B.
N Engl J Med; 2000 Mar 30; 342(13):913-20. PubMed ID: 10738049
[Abstract] [Full Text] [Related]
14. Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study.
Kosior DA, Kochanowski J, Scisło P, Piatkowski R, Postuła M, Rabczenko D, Opolski G.
Cardiol J; 2009 Mar 30; 16(6):521-7. PubMed ID: 19950088
[Abstract] [Full Text] [Related]
15. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
Arch Mal Coeur Vaiss; 1984 Nov 30; 77(12):1370-82. PubMed ID: 6439161
[Abstract] [Full Text] [Related]
16. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L, Davini A, Lattanzi F, Topi A, Reisenhofer B, Squarcini G, Paci A, Topi PL.
Minerva Cardioangiol; 1995 Oct 30; 43(10):449-57. PubMed ID: 8819814
[Abstract] [Full Text] [Related]
17. Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.
Alboni P, Botto GL, Baldi N, Luzi M, Russo V, Gianfranchi L, Marchi P, Calzolari M, Solano A, Baroffio R, Gaggioli G.
N Engl J Med; 2004 Dec 02; 351(23):2384-91. PubMed ID: 15575054
[Abstract] [Full Text] [Related]
18. [Efficacy of intravenous and per os propafenone in the ambulatory treatment of recent-onset atrial fibrillation].
Margheri M, Fradella G, Maioli M, Paterni M, Bartoli P, Bonechi F, Brandinelli A, Mazza F, Sansoni M, Zipoli A.
G Ital Cardiol; 1992 Mar 02; 22(3):257-65. PubMed ID: 1426770
[Abstract] [Full Text] [Related]
19. [A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation].
Carunchio A, Fera MS, Mazza A, Burattini M, Greco G, Galati A, Ceci V.
G Ital Cardiol; 1995 Jan 02; 25(1):51-68. PubMed ID: 7642012
[Abstract] [Full Text] [Related]
20. [Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
Komatsu T, Nakamura S, Kimura M, Owada S, Yomogida K, Kameda K, Oikawa K, Tomita H, Okumura K.
J Cardiol; 2002 Feb 02; 39(2):93-9. PubMed ID: 11873440
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
